Диссертация (1146661), страница 17
Текст из файла (страница 17)
Кasacka I. Review article – involvement of gastric APUD cells in chronicrenal failure // Acta Histochem 2003; 105 (4): Р.319-327.107. Kawashima J., Ohno S., Sakurada T., Takabayashi H., Kudo M., Ro S., KatoS. Circulating acylated ghrelin level decreases in accordance with the extent ofatrophic gastritis // J Gastroenterol. 2009;44(10): Р.1046-54.108. Kaysen GA, Kumar V.
Inflammation in ESRD: causes and potentialconsequences// J Ren Nutr. 2003 Apr;13(2): Р.158-60.109. Kaysen G.A. Malnutrition and the acute-phase reaction in dialysis patients:How to measure and how to distinguish // Nephrol. Dial. Transplant.–2000.–Vol.15.–P. 1521-1524.119110.
Kaysen G.A. Biological basis of hypoalbuminemia in ESRD // J. Am. Soc.Nephrol.–1998.–Vol. 9, № 12.–P. 2368-2376.111. Kaysen G.A. The microinflammatory state in uremia: causes and potentialconsequences // J. Am. Soc. Nephrol.–2001.–Vol. 12.–P. 1549-1557.112. Kaysen G.A., Rathore V., Shearer G.C., Depher Th.A. Mechanisms ofhypoalbuminemia in hemodialysis patients // Kidney Int.–1995.–Vol. 48, № 2.–P. 510-516.113. Kaysen G.A., Levin N.W. Why measure serum albumin levels? // J. Ren.Nutr.–2002.–Vol.
12.–P. 148-150.114. Kayali A.G., Young V.R., Goodman M.N. Sensivity of myofibrillar proteinsto glucocorticoid induced muscle proteolysis // Am. J. Physiol.–1987.–Vol. 252.–P. E621-E626.115. Kimmel P.L., Phillips T.M., Simmens S.J. et al. Immunologic function andsurvival in hemodialysis patients // Kidney Int.–1998.–Vol. 54, № 1.–P. 236-244.116.
Kloppenburg W.D., Stegeman C.A., de Jong P.E., Huisman R.M. Relatingprotein intake to nutritional status in haemodialysis patients: how to normalizethe protein equivalent of total nitrogen appearance (PNA)?// Nephrol DialTransplant. 1999 Sep;14(9): Р.2165-72.117.
Kopple J.D. National Kidney Foundation K/DOQI clinical practice.guidelines for nutrition in chronic renal failure // Am. J. Kidney Dis.–2001.– Vol.37.–P. S66-S70.118. Kopple J.D. Effect of nutrition on morbidity and mortality in maintenancedialysis patients // Am. J. Kidney Dis.–1994.–Vol. 24, № 6.–P. 1002-1009.119. Korbonits M., Goldstone A., Gueorguiev M., Grossman A. Ghrelin – agormone with multiple functions // Front Neuroend crinol 2004; 25: Р.27-68.120120. Kojima M., Kangawa K. Drug Insight the function of ghrelin and its potentialas a multitherapeutic hormone // Nature clinical practice Endocrinology andMetabolism 2006; 2 (2): Р.234-237.121. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K.Ghrelin is a growth-hormone-releasing acylated peptide from stomach.
//Nature. 1999 Dec 9; 402(6762): Р.656-60.122. Krieg J.Jr., Santos F., Chan J.C.M. Growth hormone, insulin-like growthfactor and the kidney // Kidney Int.–1995.–Vol. 48, № 2.–P. 321-336.123. Kutner N.G., Zhang R. Body mass index as a predictor of continued survivalin older chronic dialysis patients // Int. Urol. Nephrol.–2001.–Vol. 32, № 3.–P.441-448.124.Hakim R.M., Levin M. Malnutrition in hemodialysis patients // Am. J.Kidney Dis.–1993.–Vol.
21, № 2.–P. 125-137.125. Larsson J., Akerlind I., Permerth J., Hornqvist J.-O. The relation betweennutritional state and quality of life in surgical patients // Eur. J. Surg.–1994.–Vol.160, № 6–7.–P. 329-334.126. Law M.R., Morris J.K., Wald N.J. et al. Serum albumin and mortality in theBUPA study //British United Provident. Assoc. Int. J. Epidemiol.–1994.–Vol. 23,№ 1.–P. 38-41.127. Lesourd B.M., Mazari L. Immune responses during recovery from proteinenergy malnutrition // Clin. Nutr.–1997.–Vol. 16, Suppl.
1.–P. 37-46.128. Louard R.J., Fryburg D.A., Gelfand R.A., Barrett E.J. Insulin sensitivity ofprotein and glucose metabolism in human forearm skeletal muscle // J. Clin.Invest.–1992.–Vol. 90.–P. 2348-2354.129. Louden J.D., Roberts R.R., Goodship T.H.S. Acidosis and nutrition // KidneyInt.–1999.–Vol. 56, Suppl. 73.–P.
S-85-S-88.121130. Lowrie EG. Chronic dialysis treatment: clinical outcome and related processesof care// Am J Kidney Dis. 1994 Aug;24(2):255-66.131. Lowrie E.G., Lew N.L. Death risk in hemodialysis patients: the predictivevalue of commonly measured variables and an evaluation of death ratedifferences between facilities // Am. J. Kidney Dis.–1990.–Vol. 15, № 5.–P. 458482.132. Lowrie E.G., Huang W.H., Lew N.L., Liu Y. The relative contribution ofmeasured variables to death risk among hemodialysis patients // In: Friedman EA(ed).
Death on Hemodialysis. Amsterdam: Kluwer Academic.–1994.–P. 121141.133. Mak R.H., Bettinelli A., Turner C. et al. The influence of hyperparathyroidismon glucose metabolism in uremia // J. Clin. Endocrinol. Metab.–1985.–Vol. 60.–P. 229 – 233.134. Mak R.H, Cheung W.W. Is ghrelin a biomarker for mortality in end-stagerenal disease?// , Kidney Int.
2011 Apr;79(7): Р.697-9.135. Malatino L.S., Mallamaci F., Benedetto F.A. et al. Hepatocyte growth factorpredicts survival and relates to inflammation and intima media thickness in endstage renal disease// Am J Kidney Dis. 2000 Nov;36(5): Р.945-52.136. Marcén R., Teruel J.L., de la Cal M.A., Gámez C. The impact of malnutritionin morbidity and mortality in stable haemodialysis patients. Spanish CooperativeStudy of Nutrition in Hemodialysis// Nephrol Dial Transplant. 1997 Nov;12(11):Р.2324-31.137.Matsuda K., Nishi Y., Okamatsu Y., Kojima M.
et al. Ghrelin and leptin: alink between obesity and allergy // Journal of allergy and clinical Immunology(St Louis MO) 2006; 117 (3): Р.705-706.122138. Mafra D. Are Ghrelin and Leptin Involved in Food Intake and Body MassIndex in Maintenance Hemodialysis // J Renal Nutritoin 2010 May;20(3):Р.1517.139. Meier U., Gressner A. Endocrine regulation of Energy Metabolism: Reviewof Pathobiochemical and Clinical Chemical Aspects of Leptin, Ghrelin,Adiponectin and Resistin. Clinical Chemistry 2004; 50 (9):Р.
1511-1525.140. Méndez-Sánchez N. Effect of Helicobacter pylori infection in gastric ghrelinexpression and body weight // Gastroenterol 2007; 72 (4): Р. 359-364.141. Misra V., Misra S.P., Shukla S.K. Endoscopic and histological changes inupper gastrointestinal tract of patients with chronic renal failure // Indian J. PatholMicrobiol 2004; 47 (2): Р.170-173.142.
Mitch W.E. Metabolic acidosis stimulates protein metabolism in uremia //Miner. Electrolyte Metab.–1996.–Vol. 2.–P. 62-65.143. Mitch W.E., Price S.R., May R.S. et al. Metabolic consequences of uremia:extending the concept of adaptive responses to protein metabolism // Am. J.Kidney Dis.–1994.–Vol. 23, № 2.–P. 224-228.144. Movilli E., Zani R., Carli O., Sangalli L. et al. Correction of metabolic acidosisincreases serum albumin concentrations and decreases kinetically evaluatedprotein intake in haemodialysis patients: a prospective study// Nephrol DialTransplant. 1998 Jul;13(7): Р.1719-22.145.
Movilli E., Filippini M., Brunori G. et al. Influence of protein catabolic rateon nutritional status, morbidity and mortality in elderly uraemic patients onchronic haemodialysis: a prospective 3-year follow-up study// Nephrol DialTransplant. 1995;10(4): Р.514-8.146. Nair K.S., Ford G.C., Ekberg K. et al. Protein dynamics in whole body and insplanchnic and leg tissues in type I diabetic patients // J. Clin. Invest.–1995.–Vol.95.–P. 2926-2937.123147. Nardone G., Rocco A., Fiorillo M. Helicobarter pylory infection in dyspepticpatients with and without chronic renal failure // Helicobacter 2005; 10 (1): Р.53-58.148.
Naufel M.F., Bordon M., de Aquino T.M., Ribeiro E.B., de Abreu CarvalhaesPlasma levels of acylated and total ghrelin in pediatric patients with chronickidney disease. JT Pediatr Nephrol. 2010 Dec;25(12): Р.2477-82.149. Niebauer J., Clark A.L., Anker S.D., Coats A.J. Three year mortality in heartfailure patients with very low left ventricular ejection fractions.// Int J Cardiol.1999 Aug 31;70(3): Р.24.150.Nieves M., Sulbarán J., Gaona C.
et al. Gastroduodenitis and Helicobacterpylori in uremic patients// G E N. 1992 Apr-Jun;46(2): Р.113-20.151. Noori N., Kovesdy C.P., Dukkipati R. et al. Racial and ethnic differences inmortality of hemodialysis patients: role of dietary and nutritional status andinflammation// Am J Nephrol. 2011;33(2): Р.157-67.152. Nordfors L., Lonnqvist F., Heimburger O. et al. Low leptin gene expressionand hyperleptinemia in chronic renal failure // Kidney Int.–1998.–Vol. 54.–P.1267-1275.153. O’Keefe S.J., Dicker J. Is plasma albumin concentration useful in theassessment of nutritional status of hospital patients? // Eng.
J. Clin. Nutr.– 1988.–Vol. 42, № 1.–P. 41-45.154. Oksa H., Ahonen K., Pasternack A., Marnela K.-M. Malnutrition inhemodialysis patients // Scand. J. Urol. Nephrol.–1991.–Vol. 25, № 2.–P. 157161.155. Oldrizzi L., Rugiu C., De Biase V. et al. Factors influencing dietarycompliance in patients with chronic renal failure on unsupplemented low-proteindiet // Cotrib.
Nephrol.–1990.–Vol. 81.–P. 9-15.124156. Oner-Iyidogan Y., Gurdol F., Kocak H., Oner P., Cetinalp-Demircan P.,Caliskan Y., Kocak T., Turkmen A. Appetite-regulating hormones in chronickidney disease patients// J Ren Nutr. 2011 Jul;21(4): Р.316-21.157. Osawa H. Ghrelin and Helicobacter pylori infection // World J Gastroenterol2008; 14 (41): Р. 6327-6333.158. Owen W.F., Lew N.L., Liu Y. et al.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
